Status:
UNKNOWN
Photobiomodulation in Individuals With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
University of Nove de Julho
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is among the most common chronic respiratory diseases (CKD). Millions of people of all ages suffer from these diseases. COPD is between the fifth and sixth...
Eligibility Criteria
Inclusion
- Individuals of both sexes;
- Over 18 years of age;
- With a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) for at least 2 years according to the criteria of the clinically stable Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), free of disease exacerbation in the last 30 days;
- Performing routine outpatient treatment with a pulmonologist;
- Agreement to participate.
Exclusion
- Individuals with other comorbidities, such as: Acute Lung Disease, Congestive Heart Failure, Liver Failure, Pulmonary Thromboembolism, Acute Respiratory Distress Syndrome, Neoplasms, HIV Positive, Immunodeficiency, Blood Disorders, Septicemia or recent major surgery.
- Patients with cystic fibrosis and Kartagner's syndrome.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 3 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04010084
Start Date
August 1 2019
End Date
June 3 2020
Last Update
July 8 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.